Single vs Quadruple Receptor Activation# Weight Loss Data# Critical caveat: Bioglutide achieved comparable weight loss to semaglutide in 13 weeks versus 68 weeks, which if sustained would represent dramatically superior efficacy
Key takeaways TRIUMPH-4 is the first successful Phase 3 readout for retatrutide, reporting 28.7% mean body-weight reduction at 68 weeks on the 12 mg weekly dose (26.4% on 9 mg, 2.1% on placebo)
LifeMD: Pricing and insurance When comparing costs, its not just about the monthly membershipits about whats bundled in and whats billed separately
The FDA declared the semaglutide shortage resolved in February 2025 and the tirzepatide shortage resolved in late 2024, which ended the shortage-list justification that most large-scale compounding relied on
Gillespie AH, Doctor A
Yes, at HPLC 99% quality, 5/10/15/20/30/40 mg doses, with per-lot COA